Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMAT Applied Materials	$575.39 -4.5%	$521.52	$154.46 ▼ $739.67	$478.36B	1.57	11.99 million shs	7.55 million shs
PFE Pfizer	$24.46 +1.2%	$25.32	$23.11 ▼ $28.75	$137.76B	0.35	47.17 million shs	42.73 million shs
TOL Toll Brothers	$148.13 -0.9%	$144.39	$113.52 ▼ $168.36	$13.97B	1.34	1.11 million shs	740,298 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMAT Applied Materials	-4.50%	-2.94%	+1.43%	+45.43%	+190.70%
PFE Pfizer	+1.02%	+3.04%	-6.60%	-9.84%	-4.64%
TOL Toll Brothers	-0.83%	-4.45%	+0.80%	+4.29%	+22.44%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMAT Applied Materials	$575.39 -4.5%	$521.52	$154.46 ▼ $739.67	$478.36B	1.57	11.99 million shs	7.55 million shs
PFE Pfizer	$24.46 +1.2%	$25.32	$23.11 ▼ $28.75	$137.76B	0.35	47.17 million shs	42.73 million shs
TOL Toll Brothers	$148.13 -0.9%	$144.39	$113.52 ▼ $168.36	$13.97B	1.34	1.11 million shs	740,298 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMAT Applied Materials	-4.50%	-2.94%	+1.43%	+45.43%	+190.70%
PFE Pfizer	+1.02%	+3.04%	-6.60%	-9.84%	-4.64%
TOL Toll Brothers	-0.83%	-4.45%	+0.80%	+4.29%	+22.44%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMAT Applied Materials	2.85	Moderate Buy	$589.48	2.45% Upside
PFE Pfizer	2.19	Hold	$28.50	16.51% Upside
TOL Toll Brothers	2.71	Moderate Buy	$164.44	11.01% Upside

Current Analyst Ratings Breakdown

Latest AMAT, PFE, and TOL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/13/2026	PFE Pfizer	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$34.00 ➝ $30.00
7/13/2026	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$36.00 ➝ $35.00
7/10/2026	TOL Toll Brothers	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$146.00 ➝ $176.00
7/10/2026	AMAT Applied Materials	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$530.00 ➝ $650.00
7/10/2026	AMAT Applied Materials	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$530.00 ➝ $740.00
7/10/2026	PFE Pfizer	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$27.00 ➝ $26.00
7/9/2026	AMAT Applied Materials	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$525.00 ➝ $700.00
7/8/2026	AMAT Applied Materials	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$540.00 ➝ $650.00
7/8/2026	PFE Pfizer	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$30.00 ➝ $28.00
7/6/2026	PFE Pfizer	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$32.00 ➝ $28.00
7/6/2026	AMAT Applied Materials	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$502.00 ➝ $647.00

(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMAT Applied Materials	$28.37B	16.10	$9.64 per share	59.68	$25.63 per share	22.45
PFE Pfizer	$62.58B	2.23	$4.45 per share	5.50	$15.26 per share	1.60
TOL Toll Brothers	$10.97B	1.26	$14.68 per share	10.09	$85.97 per share	1.72

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMAT Applied Materials	$7.00B	$10.65	54.03	35.54	1.53	29.31%	36.97%	21.30%	8/13/2026 (Estimated)
PFE Pfizer	$7.77B	$1.31	18.67	8.55	N/A	11.83%	19.44%	8.41%	8/4/2026 (Estimated)
TOL Toll Brothers	$1.35B	$13.22	11.20	10.48	1.24	11.66%	15.47%	8.90%	8/18/2026 (Estimated)

Latest AMAT, PFE, and TOL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/4/2026	Q2 2026	PFE Pfizer	$0.68	N/A	N/A	N/A	$14.41 billion	N/A
5/19/2026	Q2 2026	TOL Toll Brothers	$2.58	$2.72	+$0.14	$2.72	$2.42 billion	$2.53 billion
5/14/2026	Q2 2026	AMAT Applied Materials	$2.68	$2.86	+$0.18	$3.51	$7.68 billion	$7.91 billion
5/5/2026	Q1 2026	PFE Pfizer	$0.7220	$0.75	+$0.0280	$0.47	$13.84 billion	$14.45 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMAT Applied Materials	$2.12	0.37%	+14.87%	19.91%	8 Years
PFE Pfizer	$1.72	7.03%	-13.20%	131.30%	16 Years
TOL Toll Brothers	$1.04	0.70%	+17.37%	7.87%	5 Years

Latest AMAT, PFE, and TOL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/9/2026	AMAT Applied Materials	quarterly	$0.53	0.42%	8/20/2026	8/20/2026	9/10/2026
6/24/2026	PFE Pfizer	quarterly	$0.43	7.15%	7/24/2026	7/24/2026	9/1/2026
6/17/2026	TOL Toll Brothers	quarterly	$0.26	0.7%	7/10/2026	7/10/2026	7/24/2026
4/22/2026	PFE Pfizer	quarterly	$0.43	6.71%	5/8/2026	5/8/2026	6/12/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMAT Applied Materials	0.22	2.51	1.80
PFE Pfizer	0.67	1.25	0.94
TOL Toll Brothers	0.33	4.67	0.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMAT Applied Materials	80.56%
PFE Pfizer	68.36%
TOL Toll Brothers	91.76%

Insider Ownership

Company	Insider Ownership
AMAT Applied Materials	0.30%
PFE Pfizer	0.62%
TOL Toll Brothers	1.37%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMAT Applied Materials	36,500	793.96 million	791.58 million	Optionable
PFE Pfizer	75,000	5.70 billion	5.66 billion	Optionable
TOL Toll Brothers	4,900	93.47 million	92.19 million	Optionable

AMAT, PFE, and TOL Headlines

Recent News About These Companies

Candriam S.C.A. Trims Stock Holdings in Toll Brothers Inc. $TOL

2 hours ago | marketbeat.com

Toll Brothers Announces Grand Opening of Torrente in Eagle, Idaho

July 13 at 4:00 PM | globenewswire.com

Hsbc Holdings PLC Has $2.26 Million Stock Holdings in Toll Brothers Inc. $TOL

July 11 at 8:24 AM | marketbeat.com

Toll Brothers (TOL) Launches New Luxury Home Communities Across California And Colorado

July 11 at 1:32 AM | finance.yahoo.com

Is Citigroup’s Upgrade of Toll Brothers (TOL) Reframing Its Role in Luxury U.S. Housing?

July 10, 2026 | finance.yahoo.com

Toll Brothers upgraded to buy at Citi on K-shaped recovery

July 10, 2026 | msn.com

Toll Brothers Announces New Luxury Home Community Coming Soon to Thousand Oaks, California

July 10, 2026 | globenewswire.com

Toll Brothers Announces New Phase of Home Sites Coming to Saddlecrest at Windermere in Fall 2026

July 10, 2026 | globenewswire.com

Here Are Friday's Best Wall Street Analyst Research Calls: CubeSmart, Digital Realty Trust, Honeywell Aerospace, IBM, PepsiCo, Seagate, Shopify, Toll Brothers, Twilio, and More

July 10, 2026 | 247wallst.com

Integrated Advisors Network LLC Reduces Position in Toll Brothers Inc. $TOL

July 10, 2026 | marketbeat.com

Toll Brothers Announces New Luxury Home Community Coming Soon to Bickford Ranch, California

July 9, 2026 | globenewswire.com

Toll Brothers Inc. (NYSE:TOL) Receives Consensus Recommendation of "Moderate Buy" from Analysts

July 9, 2026 | marketbeat.com

Toll Brothers Opens New Collections of Luxury Homes within Established Community in Berthoud, Colorado

July 8, 2026 | globenewswire.com

Toll Brothers Announces New Luxury Home Community Coming Soon to Sierra Madre, California

July 8, 2026 | globenewswire.com

Montag A & Associates Inc. Increases Stock Position in Toll Brothers Inc. $TOL

July 8, 2026 | marketbeat.com

Toll Brothers Opens Two New Townhome Collections at The Crossing at Coal Mountain in Cumming, Georgia

July 7, 2026 | globenewswire.com

Toll Brothers Announces Model Home for Sale at Regency at Ten Trails in Black Diamond, Washington

July 7, 2026 | globenewswire.com

Whittier Trust Co. of Nevada Inc. Makes New Investment in Toll Brothers Inc. $TOL

July 7, 2026 | marketbeat.com

Whittier Trust Co. Acquires Shares of 49,166 Toll Brothers Inc. $TOL

July 7, 2026 | marketbeat.com

Burney Co. Sells 7,656 Shares of Toll Brothers Inc. $TOL

July 7, 2026 | marketbeat.com

Toll Brothers (TOL) Stock Dips While Market Gains: Key Facts

July 6, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AMAT, PFE, and TOL Company Descriptions

Applied Materials NASDAQ:AMAT

$575.39 -27.11 (-4.50%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$594.48 +19.09 (+3.32%)

As of 06:19 AM Eastern

Applied Materials, Inc. engages in the provision of manufacturing equipment, services, and software to the semiconductor, display, and related industries. The company operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems segment develops, manufactures, and sells various manufacturing equipment that is used to fabricate semiconductor chips or integrated circuits. This segment also offers various technologies, including epitaxy, ion implantation, oxidation/nitridation, rapid thermal processing, physical vapor deposition, chemical vapor deposition, chemical mechanical planarization, electrochemical deposition, atomic layer deposition, etching, and selective deposition and removal, as well as metrology and inspection tools. The Applied Global Services segment provides integrated solutions to optimize equipment and fab performance and productivity comprising spares, upgrades, services, remanufactured earlier generation equipment, and factory automation software for semiconductor, display, and other products. The Display and Adjacent Markets segment offers products for manufacturing liquid crystal displays; organic light-emitting diodes; and other display technologies for TVs, monitors, laptops, personal computers, electronic tablets, smart phones, and other consumer-oriented devices. It operates in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. The company was incorporated in 1967 and is headquartered in Santa Clara, California.

Pfizer NYSE:PFE

$24.46 +0.29 (+1.20%)

Closing price 07/13/2026 03:59 PM Eastern

Extended Trading

$24.48 +0.02 (+0.08%)

As of 06:16 AM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Toll Brothers NYSE:TOL

$148.13 -1.36 (-0.91%)

Closing price 07/13/2026 03:59 PM Eastern

Extended Trading

$148.15 +0.02 (+0.02%)

As of 05:08 AM Eastern

Toll Brothers, Inc., together with its subsidiaries, designs, builds, markets, sells, and arranges finance for a range of detached and attached homes in luxury residential communities in the United States. It designs, builds, markets, and sells condominiums through Toll Brothers City Living. The company also develops a range of single-story living and first-floor primary bedroom suite home designs, as well as communities with recreational amenities, such as golf courses, marinas, pool complexes, country clubs, and fitness and recreation centers; and develops, operates, and rents apartments. In addition, it provides various interior fit-out options, such as flooring, wall tile, plumbing, cabinets, fixtures, appliances, lighting, and home-automation and security technologies. Further, the company owns and operates architectural, engineering, mortgage, title, land development, insurance, smart home technology, landscaping, lumber distribution, house component assembly, and component manufacturing operations. It serves luxury first-time, move-up, empty-nester, active-adult, and second-home buyers. Toll Brothers, Inc. was founded in 1967 and is headquartered in Fort Washington, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMAT, PFE, and TOL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMAT, PFE, and TOL Earnings

Compare Dividends

Latest AMAT, PFE, and TOL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMAT, PFE, and TOL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AMAT, PFE, and TOL Company Descriptions

Applied Materials NASDAQ:AMAT

Pfizer NYSE:PFE

Toll Brothers NYSE:TOL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMAT, PFE, and TOL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMAT, PFE, and TOL Earnings

Compare Dividends

Latest AMAT, PFE, and TOL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMAT, PFE, and TOL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AMAT, PFE, and TOL Company Descriptions

Applied Materials NASDAQ:AMAT

Pfizer NYSE:PFE

Toll Brothers NYSE:TOL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools